Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis

Priscilla McAuliffe, Funda Meric-Bernstam, Gordon Mills, Ana Gonzalez-Angulo

    Research output: Contribution to journalArticlepeer-review

    97 Scopus citations


    The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway mediates multiple cellular functions critical to tumor initiation, progression, and outcomes, including growth and proliferation, metabolism, motility, migration, invasion, angiogenesis, survival, and autophagy. Tight regulation of this pathway is paramount to ensure that multiple cellular inputs are integrated for appropriate cellular outcomes. Frequent deregulation and aberrations of this pathway have been implicated in breast cancer development and progression. This review focuses on the biology of this pathway and its role in breast cancer pathogenesis. The role of therapies directed at targeting mTOR in the PI3K/Akt/mTOR pathway, which are currently being evaluated in clinical trials, will also be reviewed.

    Original languageEnglish (US)
    Pages (from-to)S59-S65
    JournalClinical Breast Cancer
    Issue numberSUPPL. 3
    StatePublished - Nov 1 2010


    • HER2
    • Mammalian target of rapamycin
    • PTEN
    • Phosphatidylinositol 3-kinase

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Fingerprint Dive into the research topics of 'Deciphering the role of PI3K/Akt/mTOR pathway in breast cancer biology and pathogenesis'. Together they form a unique fingerprint.

    Cite this